An observational, non-interventional, multi-center study to evaluate efficacy and tolerability of high dose rosuvastatin in high risk patients after titration.
Phase of Trial: Phase III
Latest Information Update: 19 Mar 2012
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms REVORUTION
- Sponsors AstraZeneca
- 19 Mar 2012 Actual patient number (1482) added as reported by ClinicalTrials.gov.
- 30 Nov 2010 Actual initiation date changed from Aug 2007 to May 2007 as reported by ClinicalTrials.gov.
- 14 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.